MedPath

Impact of Sustained Release d-Amphetamine on Choice Between Cocaine and a Non-Drug Reinforcer

Early Phase 1
Completed
Conditions
Active Cocaine Users
Interventions
Registration Number
NCT02383043
Lead Sponsor
Joshua A. Lile, Ph.D.
Brief Summary

Cocaine-use disorders continue to be a significant public health concern, yet no effective medications have been identified. The goal of this study is to establish a research platform for the development of medications for treatment of cocaine abuse and dependence. This study will incorporate choice self-administration procedures between drug and a non-drug alternative reinforcer presented during maintenance on d-amphetamine, which has been previously shown to reduce cocaine use.

Detailed Description

Not available

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
18
Inclusion Criteria
  • Recent cocaine use, otherwise healthy
Exclusion Criteria
  • Laboratory results outside of clinically acceptable ranges, history of or current serious physical or psychiatric disease

Study & Design

Study Type
INTERVENTIONAL
Study Design
CROSSOVER
Arm && Interventions
GroupInterventionDescription
Active TreatmentSustained Release d-AmphetamineCocaine choice during d-amphetamine maintenance
Placebo TreatmentSustained Release d-AmphetamineCocaine choice during placebo maintenance
Active TreatmentCocaineCocaine choice during d-amphetamine maintenance
Placebo TreatmentCocaineCocaine choice during placebo maintenance
Primary Outcome Measures
NameTimeMethod
The Number of Times Cocaine Was Selected in the Presence of a Monetary Reward Alternative9 choice trials per cocaine dose level with each trial separated by 30 minutes

The reinforcing effects of cocaine were determined using a modified progressive ratio procedure (Lile et al., 2016) in which subjects made 9 choices between each available cocaine dose and money (US$6.00). Reinforcing effects are measured for each cocaine dose during both d-amphetamine and placebo maintenance.

Secondary Outcome Measures
NameTimeMethod

Trial Locations

Locations (1)

Laboratory of Human Behavioral Pharmacology

🇺🇸

Lexington, Kentucky, United States

Laboratory of Human Behavioral Pharmacology
🇺🇸Lexington, Kentucky, United States

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.